SEC Form 4 · accession 0001645627-18-000074
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Scott Mann
Officer — President
Period of report
Nov 21, 2018
Accepted (ET)
Nov 27, 2018 · 5:22 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 21, 2018 | P | 3,000 | $0.0276 | A | 26,200,498 | D | |
| Common Stock | Nov 21, 2018 | P | 1,000 | $0.0276 | A | 26,201,498 | D | |
| Common Stock | Nov 21, 2018 | P | 1,000 | $0.0297 | A | 26,202,498 | D | |
| Common Stock | Nov 21, 2018 | P | 2,000 | $0.0319 | A | 26,204,498 | D | |
| Common Stock | Nov 21, 2018 | P | 1,000 | $0.0303 | A | 26,205,498 | D | |
| Common Stock | Nov 21, 2018 | P | 1,000 | $0.0302 | A | 26,206,498 | D | |
| Common Stock | Nov 21, 2018 | P | 5,000 | $0.0302 | A | 26,211,498 | D | |
| Common Stock | Nov 21, 2018 | P | 1,000 | $0.0297 | A | 26,212,498 | D | |
| Common Stock | Nov 21, 2018 | P | 2,000 | $0.0297 | A | 26,214,498 | D | |
| Common Stock | Nov 23, 2018 | P | 1,000 | $0.0284 | A | 26,215,498 | D | |
| Common Stock | Nov 23, 2018 | P | 1,000 | $0.029 | A | 26,216,498 | D | |
| Common Stock | Nov 23, 2018 | P | 1,000 | $0.0275 | A | 26,217,498 | D |
Table II — derivative securities
No Table II lines on this filing.